nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP3A5—prostate cancer	0.201	0.698	CbGaD
Trazodone—CYP3A4—prostate cancer	0.0869	0.302	CbGaD
Trazodone—ORM1—Abiraterone—prostate cancer	0.0755	0.168	CbGbCtD
Trazodone—CYP3A5—Flutamide—prostate cancer	0.0255	0.0569	CbGbCtD
Trazodone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0229	0.051	CbGbCtD
Trazodone—CYP2D6—Bicalutamide—prostate cancer	0.0189	0.0421	CbGbCtD
Trazodone—CYP3A5—Cabazitaxel—prostate cancer	0.0189	0.0421	CbGbCtD
Trazodone—ABCB1—Estramustine—prostate cancer	0.0186	0.0415	CbGbCtD
Trazodone—CYP3A5—Estrone—prostate cancer	0.0185	0.0411	CbGbCtD
Trazodone—CYP2D6—Abiraterone—prostate cancer	0.0157	0.0349	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0141	0.0315	CbGbCtD
Trazodone—CYP3A7—Estradiol—prostate cancer	0.0141	0.0315	CbGbCtD
Trazodone—ABCB1—Cabazitaxel—prostate cancer	0.0123	0.0274	CbGbCtD
Trazodone—CYP3A4—Bicalutamide—prostate cancer	0.012	0.0268	CbGbCtD
Trazodone—ABCB1—Estrone—prostate cancer	0.012	0.0268	CbGbCtD
Trazodone—CYP3A4—Estramustine—prostate cancer	0.0112	0.0249	CbGbCtD
Trazodone—ABCB1—Ethinyl Estradiol—prostate cancer	0.0107	0.0239	CbGbCtD
Trazodone—CYP3A5—Estradiol—prostate cancer	0.0106	0.0236	CbGbCtD
Trazodone—CYP3A4—Abiraterone—prostate cancer	0.00996	0.0222	CbGbCtD
Trazodone—CYP3A4—Flutamide—prostate cancer	0.00996	0.0222	CbGbCtD
Trazodone—CYP3A7—Docetaxel—prostate cancer	0.00844	0.0188	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00844	0.0188	CbGbCtD
Trazodone—ABCB1—Conjugated Estrogens—prostate cancer	0.00786	0.0175	CbGbCtD
Trazodone—CYP3A4—Cabazitaxel—prostate cancer	0.00737	0.0164	CbGbCtD
Trazodone—CYP3A4—Estrone—prostate cancer	0.0072	0.016	CbGbCtD
Trazodone—ABCB1—Mitoxantrone—prostate cancer	0.00715	0.0159	CbGbCtD
Trazodone—CYP3A5—Etoposide—prostate cancer	0.00692	0.0154	CbGbCtD
Trazodone—ABCB1—Estradiol—prostate cancer	0.0069	0.0154	CbGbCtD
Trazodone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00642	0.0143	CbGbCtD
Trazodone—CYP3A5—Docetaxel—prostate cancer	0.00633	0.0141	CbGbCtD
Trazodone—ABCB1—Prednisone—prostate cancer	0.00593	0.0132	CbGbCtD
Trazodone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00471	0.0105	CbGbCtD
Trazodone—ABCB1—Etoposide—prostate cancer	0.00451	0.01	CbGbCtD
Trazodone—CYP3A4—Mitoxantrone—prostate cancer	0.00428	0.00954	CbGbCtD
Trazodone—CYP3A4—Estradiol—prostate cancer	0.00413	0.00921	CbGbCtD
Trazodone—ABCB1—Docetaxel—prostate cancer	0.00412	0.00919	CbGbCtD
Trazodone—CYP3A4—Prednisone—prostate cancer	0.00356	0.00792	CbGbCtD
Trazodone—ABCB1—Doxorubicin—prostate cancer	0.00307	0.00685	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—prostate cancer	0.0029	0.00645	CbGbCtD
Trazodone—CYP3A4—Etoposide—prostate cancer	0.0027	0.00602	CbGbCtD
Trazodone—CYP3A4—Docetaxel—prostate cancer	0.00247	0.0055	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—prostate cancer	0.00184	0.0041	CbGbCtD
Trazodone—HTR2A—urine—prostate cancer	0.000854	0.0817	CbGeAlD
Trazodone—CYP3A4—urine—prostate cancer	0.00079	0.0757	CbGeAlD
Trazodone—CYP2D6—urine—prostate cancer	0.000778	0.0744	CbGeAlD
Trazodone—Vilazodone—CYP2C18—prostate cancer	0.000752	0.222	CrCbGaD
Trazodone—ORM1—prostate gland—prostate cancer	0.00068	0.0651	CbGeAlD
Trazodone—ADRA1A—prostate gland—prostate cancer	0.000474	0.0454	CbGeAlD
Trazodone—CYP3A5—prostate gland—prostate cancer	0.000378	0.0362	CbGeAlD
Trazodone—HRH1—prostate gland—prostate cancer	0.000367	0.0351	CbGeAlD
Trazodone—ADRA2A—prostate gland—prostate cancer	0.00036	0.0345	CbGeAlD
Trazodone—HTR1A—renal system—prostate cancer	0.00035	0.0336	CbGeAlD
Trazodone—ORM1—bone marrow—prostate cancer	0.00035	0.0335	CbGeAlD
Trazodone—ADRA1A—epithelium—prostate cancer	0.000348	0.0333	CbGeAlD
Trazodone—ADRA1A—renal system—prostate cancer	0.000323	0.0309	CbGeAlD
Trazodone—Perphenazine—AOX1—prostate cancer	0.000317	0.0938	CrCbGaD
Trazodone—ADRA2A—seminal vesicle—prostate cancer	0.000305	0.0292	CbGeAlD
Trazodone—HRH1—epithelium—prostate cancer	0.00027	0.0258	CbGeAlD
Trazodone—CYP3A5—renal system—prostate cancer	0.000258	0.0247	CbGeAlD
Trazodone—HRH1—urethra—prostate cancer	0.000246	0.0235	CbGeAlD
Trazodone—ADRA2A—urethra—prostate cancer	0.000241	0.0231	CbGeAlD
Trazodone—HTR2A—epithelium—prostate cancer	0.000225	0.0216	CbGeAlD
Trazodone—ORM1—lymph node—prostate cancer	0.000217	0.0208	CbGeAlD
Trazodone—Vilazodone—CYP3A4—prostate cancer	0.000214	0.0634	CrCbGaD
Trazodone—HTR2A—renal system—prostate cancer	0.000209	0.02	CbGeAlD
Trazodone—ABCB1—prostate gland—prostate cancer	0.000201	0.0192	CbGeAlD
Trazodone—CYP3A4—renal system—prostate cancer	0.000193	0.0185	CbGeAlD
Trazodone—CYP2D6—renal system—prostate cancer	0.00019	0.0182	CbGeAlD
Trazodone—Domperidone—CYP3A5—prostate cancer	0.00019	0.0562	CrCbGaD
Trazodone—Ziprasidone—CYP3A5—prostate cancer	0.000188	0.0555	CrCbGaD
Trazodone—HTR2B—lymph node—prostate cancer	0.000183	0.0175	CbGeAlD
Trazodone—Thioproperazine—SLC22A1—prostate cancer	0.000172	0.0509	CrCbGaD
Trazodone—ABCB1—seminal vesicle—prostate cancer	0.00017	0.0163	CbGeAlD
Trazodone—HRH1—testis—prostate cancer	0.000162	0.0155	CbGeAlD
Trazodone—ADRA2A—testis—prostate cancer	0.000159	0.0152	CbGeAlD
Trazodone—Nefazodone—CYP3A5—prostate cancer	0.000158	0.0466	CrCbGaD
Trazodone—ABCB1—epithelium—prostate cancer	0.000148	0.0141	CbGeAlD
Trazodone—Aripiprazole—CYP3A5—prostate cancer	0.000147	0.0434	CrCbGaD
Trazodone—Perphenazine—CYP2C18—prostate cancer	0.000142	0.042	CrCbGaD
Trazodone—ABCB1—renal system—prostate cancer	0.000137	0.0131	CbGeAlD
Trazodone—HTR2A—testis—prostate cancer	0.000135	0.0129	CbGeAlD
Trazodone—ABCB1—urethra—prostate cancer	0.000134	0.0129	CbGeAlD
Trazodone—CYP2D6—testis—prostate cancer	0.000123	0.0118	CbGeAlD
Trazodone—HRH1—lymph node—prostate cancer	0.000117	0.0112	CbGeAlD
Trazodone—ADRA2A—lymph node—prostate cancer	0.000115	0.011	CbGeAlD
Trazodone—ABCB1—bone marrow—prostate cancer	0.000103	0.00991	CbGeAlD
Trazodone—Clozapine—CYP1B1—prostate cancer	9.89e-05	0.0293	CrCbGaD
Trazodone—Quetiapine—CYP3A5—prostate cancer	9.16e-05	0.0271	CrCbGaD
Trazodone—ABCB1—testis—prostate cancer	8.85e-05	0.00847	CbGeAlD
Trazodone—Domperidone—CYP3A4—prostate cancer	8.22e-05	0.0243	CrCbGaD
Trazodone—Fluphenazine—CYP2E1—prostate cancer	8.12e-05	0.024	CrCbGaD
Trazodone—Ziprasidone—CYP3A4—prostate cancer	8.12e-05	0.024	CrCbGaD
Trazodone—Clozapine—CYP2A6—prostate cancer	7.63e-05	0.0226	CrCbGaD
Trazodone—Nefazodone—CYP3A4—prostate cancer	6.82e-05	0.0202	CrCbGaD
Trazodone—ABCB1—lymph node—prostate cancer	6.41e-05	0.00614	CbGeAlD
Trazodone—Perphenazine—CYP2C19—prostate cancer	6.36e-05	0.0188	CrCbGaD
Trazodone—Aripiprazole—CYP3A4—prostate cancer	6.34e-05	0.0188	CrCbGaD
Trazodone—Quetiapine—CYP2C19—prostate cancer	6.23e-05	0.0184	CrCbGaD
Trazodone—Prochlorperazine—CYP3A4—prostate cancer	5.65e-05	0.0167	CrCbGaD
Trazodone—Clozapine—CYP2E1—prostate cancer	5.41e-05	0.016	CrCbGaD
Trazodone—Clozapine—CYP2C19—prostate cancer	5.36e-05	0.0159	CrCbGaD
Trazodone—Clozapine—CYP1A1—prostate cancer	5.34e-05	0.0158	CrCbGaD
Trazodone—Weight increased—Doxorubicin—prostate cancer	4.89e-05	0.000295	CcSEcCtD
Trazodone—Discomfort—Capecitabine—prostate cancer	4.89e-05	0.000295	CcSEcCtD
Trazodone—Vision blurred—Prednisone—prostate cancer	4.88e-05	0.000295	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—prostate cancer	4.86e-05	0.000294	CcSEcCtD
Trazodone—Feeling abnormal—Etoposide—prostate cancer	4.86e-05	0.000293	CcSEcCtD
Trazodone—Diarrhoea—Mitoxantrone—prostate cancer	4.85e-05	0.000293	CcSEcCtD
Trazodone—Dry mouth—Capecitabine—prostate cancer	4.84e-05	0.000292	CcSEcCtD
Trazodone—Vomiting—Estradiol—prostate cancer	4.83e-05	0.000292	CcSEcCtD
Trazodone—Gastrointestinal pain—Etoposide—prostate cancer	4.82e-05	0.000291	CcSEcCtD
Trazodone—Shock—Docetaxel—prostate cancer	4.82e-05	0.000291	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisone—prostate cancer	4.8e-05	0.00029	CcSEcCtD
Trazodone—Rash—Estradiol—prostate cancer	4.79e-05	0.00029	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—prostate cancer	4.79e-05	0.000289	CcSEcCtD
Trazodone—Dermatitis—Estradiol—prostate cancer	4.79e-05	0.000289	CcSEcCtD
Trazodone—Anaemia—Prednisone—prostate cancer	4.78e-05	0.000289	CcSEcCtD
Trazodone—Confusional state—Capecitabine—prostate cancer	4.78e-05	0.000289	CcSEcCtD
Trazodone—Tachycardia—Docetaxel—prostate cancer	4.78e-05	0.000289	CcSEcCtD
Trazodone—Headache—Estradiol—prostate cancer	4.76e-05	0.000288	CcSEcCtD
Trazodone—Agitation—Prednisone—prostate cancer	4.75e-05	0.000287	CcSEcCtD
Trazodone—Oedema—Capecitabine—prostate cancer	4.74e-05	0.000286	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—prostate cancer	4.73e-05	0.000286	CcSEcCtD
Trazodone—Urticaria—Etoposide—prostate cancer	4.68e-05	0.000283	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—prostate cancer	4.67e-05	0.000282	CcSEcCtD
Trazodone—Anorexia—Docetaxel—prostate cancer	4.67e-05	0.000282	CcSEcCtD
Trazodone—Malaise—Prednisone—prostate cancer	4.67e-05	0.000282	CcSEcCtD
Trazodone—Shock—Capecitabine—prostate cancer	4.66e-05	0.000282	CcSEcCtD
Trazodone—Abdominal pain—Etoposide—prostate cancer	4.66e-05	0.000281	CcSEcCtD
Trazodone—Body temperature increased—Etoposide—prostate cancer	4.66e-05	0.000281	CcSEcCtD
Trazodone—Vertigo—Prednisone—prostate cancer	4.65e-05	0.000281	CcSEcCtD
Trazodone—Syncope—Prednisone—prostate cancer	4.64e-05	0.00028	CcSEcCtD
Trazodone—Tachycardia—Capecitabine—prostate cancer	4.63e-05	0.000279	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—prostate cancer	4.63e-05	0.000279	CcSEcCtD
Trazodone—Sweating—Doxorubicin—prostate cancer	4.59e-05	0.000277	CcSEcCtD
Trazodone—Hyperhidrosis—Capecitabine—prostate cancer	4.58e-05	0.000277	CcSEcCtD
Trazodone—Hypotension—Docetaxel—prostate cancer	4.58e-05	0.000276	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—prostate cancer	4.57e-05	0.000276	CcSEcCtD
Trazodone—Loss of consciousness—Prednisone—prostate cancer	4.55e-05	0.000275	CcSEcCtD
Trazodone—Anorexia—Capecitabine—prostate cancer	4.52e-05	0.000273	CcSEcCtD
Trazodone—Nausea—Estradiol—prostate cancer	4.52e-05	0.000273	CcSEcCtD
Trazodone—Vomiting—Mitoxantrone—prostate cancer	4.5e-05	0.000272	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—prostate cancer	4.48e-05	0.000271	CcSEcCtD
Trazodone—Hypertension—Prednisone—prostate cancer	4.47e-05	0.00027	CcSEcCtD
Trazodone—Rash—Mitoxantrone—prostate cancer	4.47e-05	0.00027	CcSEcCtD
Trazodone—Dermatitis—Mitoxantrone—prostate cancer	4.46e-05	0.00027	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.46e-05	0.000269	CcSEcCtD
Trazodone—Headache—Mitoxantrone—prostate cancer	4.44e-05	0.000268	CcSEcCtD
Trazodone—Hypotension—Capecitabine—prostate cancer	4.43e-05	0.000268	CcSEcCtD
Trazodone—Insomnia—Docetaxel—prostate cancer	4.43e-05	0.000268	CcSEcCtD
Trazodone—Arthralgia—Prednisone—prostate cancer	4.41e-05	0.000266	CcSEcCtD
Trazodone—Myalgia—Prednisone—prostate cancer	4.41e-05	0.000266	CcSEcCtD
Trazodone—Paraesthesia—Docetaxel—prostate cancer	4.4e-05	0.000266	CcSEcCtD
Trazodone—Anxiety—Prednisone—prostate cancer	4.39e-05	0.000265	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—prostate cancer	4.38e-05	0.000264	CcSEcCtD
Trazodone—Dyspnoea—Docetaxel—prostate cancer	4.37e-05	0.000264	CcSEcCtD
Trazodone—Somnolence—Docetaxel—prostate cancer	4.35e-05	0.000263	CcSEcCtD
Trazodone—Discomfort—Prednisone—prostate cancer	4.35e-05	0.000263	CcSEcCtD
Trazodone—Hypersensitivity—Etoposide—prostate cancer	4.34e-05	0.000262	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—prostate cancer	4.33e-05	0.000262	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.32e-05	0.000261	CcSEcCtD
Trazodone—Flushing—Epirubicin—prostate cancer	4.31e-05	0.000261	CcSEcCtD
Trazodone—Insomnia—Capecitabine—prostate cancer	4.29e-05	0.000259	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—prostate cancer	4.28e-05	0.000259	CcSEcCtD
Trazodone—Paraesthesia—Capecitabine—prostate cancer	4.26e-05	0.000257	CcSEcCtD
Trazodone—Decreased appetite—Docetaxel—prostate cancer	4.26e-05	0.000257	CcSEcCtD
Trazodone—Asthenia—Etoposide—prostate cancer	4.23e-05	0.000255	CcSEcCtD
Trazodone—Dyspnoea—Capecitabine—prostate cancer	4.23e-05	0.000255	CcSEcCtD
Trazodone—Oedema—Prednisone—prostate cancer	4.22e-05	0.000255	CcSEcCtD
Trazodone—Fatigue—Docetaxel—prostate cancer	4.22e-05	0.000255	CcSEcCtD
Trazodone—Nausea—Mitoxantrone—prostate cancer	4.21e-05	0.000254	CcSEcCtD
Trazodone—Constipation—Docetaxel—prostate cancer	4.19e-05	0.000253	CcSEcCtD
Trazodone—Pain—Docetaxel—prostate cancer	4.19e-05	0.000253	CcSEcCtD
Trazodone—Chills—Epirubicin—prostate cancer	4.17e-05	0.000252	CcSEcCtD
Trazodone—Pruritus—Etoposide—prostate cancer	4.17e-05	0.000252	CcSEcCtD
Trazodone—Shock—Prednisone—prostate cancer	4.15e-05	0.000251	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—prostate cancer	4.15e-05	0.000251	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—prostate cancer	4.15e-05	0.00025	CcSEcCtD
Trazodone—Tachycardia—Prednisone—prostate cancer	4.12e-05	0.000249	CcSEcCtD
Trazodone—Decreased appetite—Capecitabine—prostate cancer	4.12e-05	0.000249	CcSEcCtD
Trazodone—Alopecia—Epirubicin—prostate cancer	4.11e-05	0.000248	CcSEcCtD
Trazodone—Fatigue—Capecitabine—prostate cancer	4.09e-05	0.000247	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—prostate cancer	4.08e-05	0.000247	CcSEcCtD
Trazodone—Pain—Capecitabine—prostate cancer	4.05e-05	0.000245	CcSEcCtD
Trazodone—Constipation—Capecitabine—prostate cancer	4.05e-05	0.000245	CcSEcCtD
Trazodone—Perphenazine—CYP3A4—prostate cancer	4.04e-05	0.012	CrCbGaD
Trazodone—Feeling abnormal—Docetaxel—prostate cancer	4.03e-05	0.000244	CcSEcCtD
Trazodone—Diarrhoea—Etoposide—prostate cancer	4.03e-05	0.000243	CcSEcCtD
Trazodone—Anorexia—Prednisone—prostate cancer	4.03e-05	0.000243	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—prostate cancer	4.01e-05	0.000242	CcSEcCtD
Trazodone—Gastrointestinal pain—Docetaxel—prostate cancer	4e-05	0.000242	CcSEcCtD
Trazodone—Flushing—Doxorubicin—prostate cancer	3.99e-05	0.000241	CcSEcCtD
Trazodone—Flatulence—Epirubicin—prostate cancer	3.99e-05	0.000241	CcSEcCtD
Trazodone—Tension—Epirubicin—prostate cancer	3.97e-05	0.00024	CcSEcCtD
Trazodone—Quetiapine—CYP3A4—prostate cancer	3.96e-05	0.0117	CrCbGaD
Trazodone—Dysgeusia—Epirubicin—prostate cancer	3.96e-05	0.000239	CcSEcCtD
Trazodone—Nervousness—Epirubicin—prostate cancer	3.93e-05	0.000237	CcSEcCtD
Trazodone—Back pain—Epirubicin—prostate cancer	3.91e-05	0.000236	CcSEcCtD
Trazodone—Feeling abnormal—Capecitabine—prostate cancer	3.91e-05	0.000236	CcSEcCtD
Trazodone—Dizziness—Etoposide—prostate cancer	3.9e-05	0.000235	CcSEcCtD
Trazodone—Gastrointestinal pain—Capecitabine—prostate cancer	3.88e-05	0.000234	CcSEcCtD
Trazodone—Body temperature increased—Docetaxel—prostate cancer	3.87e-05	0.000234	CcSEcCtD
Trazodone—Abdominal pain—Docetaxel—prostate cancer	3.87e-05	0.000234	CcSEcCtD
Trazodone—Chills—Doxorubicin—prostate cancer	3.86e-05	0.000233	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—prostate cancer	3.85e-05	0.000232	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—prostate cancer	3.84e-05	0.000232	CcSEcCtD
Trazodone—Insomnia—Prednisone—prostate cancer	3.82e-05	0.000231	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—prostate cancer	3.81e-05	0.00023	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—prostate cancer	3.8e-05	0.00023	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—prostate cancer	3.79e-05	0.000229	CcSEcCtD
Trazodone—Urticaria—Capecitabine—prostate cancer	3.77e-05	0.000227	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—prostate cancer	3.75e-05	0.000227	CcSEcCtD
Trazodone—Abdominal pain—Capecitabine—prostate cancer	3.75e-05	0.000226	CcSEcCtD
Trazodone—Body temperature increased—Capecitabine—prostate cancer	3.75e-05	0.000226	CcSEcCtD
Trazodone—Vomiting—Etoposide—prostate cancer	3.75e-05	0.000226	CcSEcCtD
Trazodone—Anaemia—Epirubicin—prostate cancer	3.74e-05	0.000226	CcSEcCtD
Trazodone—Agitation—Epirubicin—prostate cancer	3.72e-05	0.000225	CcSEcCtD
Trazodone—Rash—Etoposide—prostate cancer	3.71e-05	0.000224	CcSEcCtD
Trazodone—Dermatitis—Etoposide—prostate cancer	3.71e-05	0.000224	CcSEcCtD
Trazodone—Headache—Etoposide—prostate cancer	3.69e-05	0.000223	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—prostate cancer	3.69e-05	0.000223	CcSEcCtD
Trazodone—Tension—Doxorubicin—prostate cancer	3.67e-05	0.000222	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—prostate cancer	3.67e-05	0.000222	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—prostate cancer	3.67e-05	0.000221	CcSEcCtD
Trazodone—Malaise—Epirubicin—prostate cancer	3.65e-05	0.00022	CcSEcCtD
Trazodone—Fatigue—Prednisone—prostate cancer	3.64e-05	0.00022	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—prostate cancer	3.64e-05	0.00022	CcSEcCtD
Trazodone—Vertigo—Epirubicin—prostate cancer	3.64e-05	0.00022	CcSEcCtD
Trazodone—Syncope—Epirubicin—prostate cancer	3.63e-05	0.000219	CcSEcCtD
Trazodone—Back pain—Doxorubicin—prostate cancer	3.62e-05	0.000219	CcSEcCtD
Trazodone—Constipation—Prednisone—prostate cancer	3.61e-05	0.000218	CcSEcCtD
Trazodone—Hypersensitivity—Docetaxel—prostate cancer	3.61e-05	0.000218	CcSEcCtD
Trazodone—Palpitations—Epirubicin—prostate cancer	3.58e-05	0.000216	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—prostate cancer	3.56e-05	0.000215	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—prostate cancer	3.53e-05	0.000213	CcSEcCtD
Trazodone—Asthenia—Docetaxel—prostate cancer	3.51e-05	0.000212	CcSEcCtD
Trazodone—Nausea—Etoposide—prostate cancer	3.5e-05	0.000211	CcSEcCtD
Trazodone—Hypertension—Epirubicin—prostate cancer	3.49e-05	0.000211	CcSEcCtD
Trazodone—Hypersensitivity—Capecitabine—prostate cancer	3.49e-05	0.000211	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—prostate cancer	3.48e-05	0.00021	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—prostate cancer	3.47e-05	0.00021	CcSEcCtD
Trazodone—Pruritus—Docetaxel—prostate cancer	3.46e-05	0.000209	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—prostate cancer	3.46e-05	0.000209	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—prostate cancer	3.45e-05	0.000209	CcSEcCtD
Trazodone—Chest pain—Epirubicin—prostate cancer	3.45e-05	0.000208	CcSEcCtD
Trazodone—Myalgia—Epirubicin—prostate cancer	3.45e-05	0.000208	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—prostate cancer	3.45e-05	0.000208	CcSEcCtD
Trazodone—Agitation—Doxorubicin—prostate cancer	3.44e-05	0.000208	CcSEcCtD
Trazodone—Anxiety—Epirubicin—prostate cancer	3.43e-05	0.000207	CcSEcCtD
Trazodone—Clozapine—CYP3A4—prostate cancer	3.41e-05	0.0101	CrCbGaD
Trazodone—Discomfort—Epirubicin—prostate cancer	3.4e-05	0.000206	CcSEcCtD
Trazodone—Asthenia—Capecitabine—prostate cancer	3.4e-05	0.000205	CcSEcCtD
Trazodone—Malaise—Doxorubicin—prostate cancer	3.38e-05	0.000204	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—prostate cancer	3.37e-05	0.000204	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—prostate cancer	3.36e-05	0.000203	CcSEcCtD
Trazodone—Syncope—Doxorubicin—prostate cancer	3.36e-05	0.000203	CcSEcCtD
Trazodone—Urticaria—Prednisone—prostate cancer	3.35e-05	0.000203	CcSEcCtD
Trazodone—Pruritus—Capecitabine—prostate cancer	3.35e-05	0.000203	CcSEcCtD
Trazodone—Diarrhoea—Docetaxel—prostate cancer	3.35e-05	0.000202	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—prostate cancer	3.34e-05	0.000202	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—prostate cancer	3.34e-05	0.000202	CcSEcCtD
Trazodone—Confusional state—Epirubicin—prostate cancer	3.33e-05	0.000201	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—prostate cancer	3.31e-05	0.0002	CcSEcCtD
Trazodone—Oedema—Epirubicin—prostate cancer	3.3e-05	0.000199	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—prostate cancer	3.29e-05	0.000199	CcSEcCtD
Trazodone—Shock—Epirubicin—prostate cancer	3.25e-05	0.000196	CcSEcCtD
Trazodone—Diarrhoea—Capecitabine—prostate cancer	3.24e-05	0.000196	CcSEcCtD
Trazodone—Dizziness—Docetaxel—prostate cancer	3.24e-05	0.000196	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—prostate cancer	3.23e-05	0.000195	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—prostate cancer	3.22e-05	0.000195	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—prostate cancer	3.19e-05	0.000193	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—prostate cancer	3.19e-05	0.000193	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—prostate cancer	3.19e-05	0.000193	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—prostate cancer	3.19e-05	0.000193	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—prostate cancer	3.18e-05	0.000192	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—prostate cancer	3.15e-05	0.00019	CcSEcCtD
Trazodone—Anorexia—Epirubicin—prostate cancer	3.15e-05	0.00019	CcSEcCtD
Trazodone—Dizziness—Capecitabine—prostate cancer	3.13e-05	0.000189	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—prostate cancer	3.12e-05	0.000188	CcSEcCtD
Trazodone—Vomiting—Docetaxel—prostate cancer	3.11e-05	0.000188	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—prostate cancer	3.11e-05	0.000188	CcSEcCtD
Trazodone—Rash—Docetaxel—prostate cancer	3.09e-05	0.000186	CcSEcCtD
Trazodone—Hypotension—Epirubicin—prostate cancer	3.09e-05	0.000186	CcSEcCtD
Trazodone—Dermatitis—Docetaxel—prostate cancer	3.08e-05	0.000186	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—prostate cancer	3.08e-05	0.000186	CcSEcCtD
Trazodone—Headache—Docetaxel—prostate cancer	3.07e-05	0.000185	CcSEcCtD
Trazodone—Oedema—Doxorubicin—prostate cancer	3.06e-05	0.000185	CcSEcCtD
Trazodone—Asthenia—Prednisone—prostate cancer	3.03e-05	0.000183	CcSEcCtD
Trazodone—Vomiting—Capecitabine—prostate cancer	3.01e-05	0.000182	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.01e-05	0.000182	CcSEcCtD
Trazodone—Shock—Doxorubicin—prostate cancer	3.01e-05	0.000182	CcSEcCtD
Trazodone—Rash—Capecitabine—prostate cancer	2.99e-05	0.000181	CcSEcCtD
Trazodone—Pruritus—Prednisone—prostate cancer	2.99e-05	0.00018	CcSEcCtD
Trazodone—Insomnia—Epirubicin—prostate cancer	2.99e-05	0.00018	CcSEcCtD
Trazodone—Dermatitis—Capecitabine—prostate cancer	2.99e-05	0.00018	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—prostate cancer	2.98e-05	0.00018	CcSEcCtD
Trazodone—Headache—Capecitabine—prostate cancer	2.97e-05	0.000179	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—prostate cancer	2.97e-05	0.000179	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—prostate cancer	2.95e-05	0.000178	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—prostate cancer	2.94e-05	0.000178	CcSEcCtD
Trazodone—Somnolence—Epirubicin—prostate cancer	2.94e-05	0.000177	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—prostate cancer	2.91e-05	0.000176	CcSEcCtD
Trazodone—Nausea—Docetaxel—prostate cancer	2.91e-05	0.000176	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—prostate cancer	2.89e-05	0.000175	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—prostate cancer	2.87e-05	0.000173	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—prostate cancer	2.86e-05	0.000172	CcSEcCtD
Trazodone—Fatigue—Epirubicin—prostate cancer	2.85e-05	0.000172	CcSEcCtD
Trazodone—Constipation—Epirubicin—prostate cancer	2.82e-05	0.000171	CcSEcCtD
Trazodone—Pain—Epirubicin—prostate cancer	2.82e-05	0.000171	CcSEcCtD
Trazodone—Nausea—Capecitabine—prostate cancer	2.82e-05	0.00017	CcSEcCtD
Trazodone—Dizziness—Prednisone—prostate cancer	2.79e-05	0.000169	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.78e-05	0.000168	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—prostate cancer	2.76e-05	0.000167	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—prostate cancer	2.74e-05	0.000166	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—prostate cancer	2.72e-05	0.000165	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—prostate cancer	2.72e-05	0.000164	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—prostate cancer	2.72e-05	0.000164	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—prostate cancer	2.7e-05	0.000163	CcSEcCtD
Trazodone—Vomiting—Prednisone—prostate cancer	2.68e-05	0.000162	CcSEcCtD
Trazodone—Rash—Prednisone—prostate cancer	2.66e-05	0.000161	CcSEcCtD
Trazodone—Dermatitis—Prednisone—prostate cancer	2.66e-05	0.000161	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—prostate cancer	2.66e-05	0.00016	CcSEcCtD
Trazodone—Headache—Prednisone—prostate cancer	2.65e-05	0.00016	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—prostate cancer	2.63e-05	0.000159	CcSEcCtD
Trazodone—Urticaria—Epirubicin—prostate cancer	2.62e-05	0.000158	CcSEcCtD
Trazodone—Constipation—Doxorubicin—prostate cancer	2.61e-05	0.000158	CcSEcCtD
Trazodone—Pain—Doxorubicin—prostate cancer	2.61e-05	0.000158	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—prostate cancer	2.61e-05	0.000158	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—prostate cancer	2.61e-05	0.000158	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—prostate cancer	2.52e-05	0.000152	CcSEcCtD
Trazodone—Nausea—Prednisone—prostate cancer	2.51e-05	0.000152	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—prostate cancer	2.5e-05	0.000151	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—prostate cancer	2.43e-05	0.000147	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—prostate cancer	2.43e-05	0.000147	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—prostate cancer	2.42e-05	0.000146	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—prostate cancer	2.42e-05	0.000146	CcSEcCtD
Trazodone—Asthenia—Epirubicin—prostate cancer	2.37e-05	0.000143	CcSEcCtD
Trazodone—Pruritus—Epirubicin—prostate cancer	2.34e-05	0.000141	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—prostate cancer	2.26e-05	0.000136	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—prostate cancer	2.25e-05	0.000136	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—prostate cancer	2.19e-05	0.000132	CcSEcCtD
Trazodone—Dizziness—Epirubicin—prostate cancer	2.18e-05	0.000132	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—prostate cancer	2.16e-05	0.000131	CcSEcCtD
Trazodone—Vomiting—Epirubicin—prostate cancer	2.1e-05	0.000127	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—prostate cancer	2.09e-05	0.000126	CcSEcCtD
Trazodone—Rash—Epirubicin—prostate cancer	2.08e-05	0.000126	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—prostate cancer	2.08e-05	0.000126	CcSEcCtD
Trazodone—Headache—Epirubicin—prostate cancer	2.07e-05	0.000125	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—prostate cancer	2.02e-05	0.000122	CcSEcCtD
Trazodone—Nausea—Epirubicin—prostate cancer	1.96e-05	0.000118	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—prostate cancer	1.94e-05	0.000117	CcSEcCtD
Trazodone—Rash—Doxorubicin—prostate cancer	1.93e-05	0.000116	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—prostate cancer	1.93e-05	0.000116	CcSEcCtD
Trazodone—Headache—Doxorubicin—prostate cancer	1.91e-05	0.000116	CcSEcCtD
Trazodone—Nausea—Doxorubicin—prostate cancer	1.82e-05	0.00011	CcSEcCtD
Trazodone—HTR2A—Signaling Pathways—NOS3—prostate cancer	2.1e-06	2.5e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOS3—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDKN1B—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARA—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NOS3—prostate cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—prostate cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CAV1—prostate cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FGF2—prostate cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—prostate cancer	2.08e-06	2.46e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—prostate cancer	2.07e-06	2.45e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—prostate cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NQO1—prostate cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOS3—prostate cancer	2.06e-06	2.44e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—prostate cancer	2.06e-06	2.44e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—prostate cancer	2.05e-06	2.44e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—prostate cancer	2.05e-06	2.44e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JAK2—prostate cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—prostate cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JAK2—prostate cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TH—prostate cancer	2.03e-06	2.41e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	2.03e-06	2.4e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—prostate cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	2.01e-06	2.38e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	2e-06	2.38e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CA—prostate cancer	2e-06	2.38e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JAK2—prostate cancer	2e-06	2.38e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—prostate cancer	2e-06	2.38e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	2e-06	2.37e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MDM2—prostate cancer	2e-06	2.37e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MDM2—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—prostate cancer	1.99e-06	2.36e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	1.98e-06	2.35e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CTNNB1—prostate cancer	1.98e-06	2.35e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.98e-06	2.35e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAV1—prostate cancer	1.97e-06	2.34e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB2—prostate cancer	1.97e-06	2.33e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB2—prostate cancer	1.96e-06	2.33e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	1.96e-06	2.33e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MDM2—prostate cancer	1.95e-06	2.32e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—prostate cancer	1.95e-06	2.32e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—prostate cancer	1.95e-06	2.31e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	1.95e-06	2.31e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—prostate cancer	1.94e-06	2.31e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CB—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FGF2—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CB—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—prostate cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—prostate cancer	1.92e-06	2.28e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GGT1—prostate cancer	1.92e-06	2.27e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOS3—prostate cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.91e-06	2.26e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	1.9e-06	2.26e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—prostate cancer	1.89e-06	2.25e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.89e-06	2.24e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—prostate cancer	1.88e-06	2.24e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL8—prostate cancer	1.87e-06	2.21e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL8—prostate cancer	1.86e-06	2.21e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.86e-06	2.21e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JAK2—prostate cancer	1.86e-06	2.21e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EP300—prostate cancer	1.85e-06	2.2e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EP300—prostate cancer	1.84e-06	2.19e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KRAS—prostate cancer	1.84e-06	2.18e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	1.83e-06	2.17e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—prostate cancer	1.83e-06	2.17e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.82e-06	2.16e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	1.82e-06	2.16e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.82e-06	2.16e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.82e-06	2.15e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—INS—prostate cancer	1.8e-06	2.14e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	1.8e-06	2.14e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SRC—prostate cancer	1.8e-06	2.14e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.8e-06	2.13e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.8e-06	2.13e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RXRA—prostate cancer	1.8e-06	2.13e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SRC—prostate cancer	1.79e-06	2.13e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.79e-06	2.12e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—prostate cancer	1.79e-06	2.12e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.78e-06	2.12e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—prostate cancer	1.78e-06	2.12e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—prostate cancer	1.78e-06	2.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—prostate cancer	1.78e-06	2.11e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—prostate cancer	1.77e-06	2.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—prostate cancer	1.77e-06	2.1e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CREBBP—prostate cancer	1.77e-06	2.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.77e-06	2.1e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.76e-06	2.09e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—prostate cancer	1.75e-06	2.08e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.75e-06	2.07e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.75e-06	2.07e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—prostate cancer	1.75e-06	2.07e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—EP300—prostate cancer	1.74e-06	2.07e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—prostate cancer	1.74e-06	2.06e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.74e-06	2.06e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—prostate cancer	1.74e-06	2.06e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—prostate cancer	1.73e-06	2.06e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—COMT—prostate cancer	1.73e-06	2.05e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—prostate cancer	1.73e-06	2.05e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.7e-06	2.02e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—INS—prostate cancer	1.7e-06	2.02e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.7e-06	2.01e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.69e-06	2e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.69e-06	2e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.69e-06	2e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—prostate cancer	1.68e-06	2e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.68e-06	2e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.68e-06	1.99e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.68e-06	1.99e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.68e-06	1.99e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—prostate cancer	1.67e-06	1.99e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—prostate cancer	1.67e-06	1.98e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.67e-06	1.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.66e-06	1.97e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.65e-06	1.96e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.65e-06	1.95e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.64e-06	1.95e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.64e-06	1.95e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.64e-06	1.94e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—prostate cancer	1.63e-06	1.94e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.63e-06	1.94e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.63e-06	1.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.62e-06	1.93e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.62e-06	1.92e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.61e-06	1.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—prostate cancer	1.61e-06	1.91e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.61e-06	1.91e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—prostate cancer	1.61e-06	1.91e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TYMS—prostate cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EP300—prostate cancer	1.6e-06	1.9e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EP300—prostate cancer	1.6e-06	1.89e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—EP300—prostate cancer	1.6e-06	1.89e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NOS3—prostate cancer	1.58e-06	1.88e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.58e-06	1.88e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.58e-06	1.88e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.58e-06	1.87e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.58e-06	1.87e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.57e-06	1.86e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.57e-06	1.86e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.57e-06	1.86e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SRC—prostate cancer	1.56e-06	1.85e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—LPL—prostate cancer	1.55e-06	1.84e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SRC—prostate cancer	1.55e-06	1.84e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.54e-06	1.82e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.53e-06	1.82e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.53e-06	1.81e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.52e-06	1.8e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.5e-06	1.78e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.5e-06	1.78e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—prostate cancer	1.5e-06	1.78e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—prostate cancer	1.5e-06	1.78e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NOS3—prostate cancer	1.49e-06	1.77e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.49e-06	1.77e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.49e-06	1.77e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.49e-06	1.76e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.48e-06	1.76e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.48e-06	1.76e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.47e-06	1.74e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.46e-06	1.73e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.46e-06	1.73e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—prostate cancer	1.45e-06	1.72e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.42e-06	1.68e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.4e-06	1.66e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—prostate cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—prostate cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.38e-06	1.64e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.38e-06	1.64e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.38e-06	1.63e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARA—prostate cancer	1.37e-06	1.63e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.37e-06	1.63e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.37e-06	1.62e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.37e-06	1.62e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.36e-06	1.62e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—prostate cancer	1.36e-06	1.61e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.34e-06	1.58e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—prostate cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—prostate cancer	1.33e-06	1.57e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—prostate cancer	1.32e-06	1.56e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAV1—prostate cancer	1.29e-06	1.53e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.29e-06	1.53e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.29e-06	1.53e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KRAS—prostate cancer	1.29e-06	1.53e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.27e-06	1.51e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.27e-06	1.5e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—prostate cancer	1.26e-06	1.5e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.26e-06	1.5e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.24e-06	1.47e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—prostate cancer	1.21e-06	1.44e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—prostate cancer	1.21e-06	1.43e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—EP300—prostate cancer	1.2e-06	1.43e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—prostate cancer	1.19e-06	1.41e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	1.18e-06	1.4e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.18e-06	1.4e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.18e-06	1.4e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.17e-06	1.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1.17e-06	1.39e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	1.16e-06	1.38e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—prostate cancer	1.15e-06	1.36e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—prostate cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—EP300—prostate cancer	1.13e-06	1.35e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—prostate cancer	1.12e-06	1.33e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.12e-06	1.33e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.11e-06	1.32e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—INS—prostate cancer	1.11e-06	1.32e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.09e-06	1.29e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	1.08e-06	1.28e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—prostate cancer	1.05e-06	1.25e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—prostate cancer	1.05e-06	1.24e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—prostate cancer	1.05e-06	1.24e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—prostate cancer	1.04e-06	1.24e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.03e-06	1.23e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—prostate cancer	1.03e-06	1.22e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NOS3—prostate cancer	9.75e-07	1.16e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—prostate cancer	9.67e-07	1.15e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—prostate cancer	9.65e-07	1.14e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—prostate cancer	9.64e-07	1.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—prostate cancer	9.54e-07	1.13e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—prostate cancer	9.47e-07	1.12e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CB—prostate cancer	9e-07	1.07e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—prostate cancer	8.92e-07	1.06e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CA—prostate cancer	8.91e-07	1.06e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—prostate cancer	8.8e-07	1.04e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CA—prostate cancer	8.39e-07	9.96e-06	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—prostate cancer	7.78e-07	9.23e-06	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—EP300—prostate cancer	7.42e-07	8.8e-06	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—prostate cancer	7.27e-07	8.63e-06	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—prostate cancer	6.86e-07	8.13e-06	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.49e-07	6.51e-06	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—prostate cancer	4.48e-07	5.32e-06	CbGpPWpGaD
